RAPP — Rapport Therapeutics, Inc. Common Stock stock price, charts and financials

QT61Rapport Therapeutics, Inc. Common Stock

Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
42.20
+1.41+3.46%
OverviewShort InterestFilings
RAPPQT61Rapport Therapeutics, Inc. Common Stock·NASDAQ
42.20+3.46%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 29, 20264Statement of changes in beneficial ownership
Jul 15, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
May 28, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026ARSAnnual report to shareholders
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 21, 20264Statement of changes in beneficial ownership
Apr 21, 20264Statement of changes in beneficial ownership
Apr 21, 20268-KCurrent report
#1 / 25 of 184
Page
▼
/ 8